Thermo Fisher Scientific Current Ratio 2010-2022 | TMO

Current and historical current ratio for Thermo Fisher Scientific (TMO) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Thermo Fisher Scientific current ratio for the three months ending June 30, 2022 was 1.65.
Thermo Fisher Scientific Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-06-30 $18.10B $11.00B 1.65
2022-03-31 $18.78B $12.07B 1.56
2021-12-31 $20.11B $13.44B 1.50
2021-09-30 $24.72B $7.75B 3.19
2021-06-30 $19.26B $6.93B 2.78
2021-03-31 $17.69B $7.00B 2.53
2020-12-31 $21.96B $10.30B 2.13
2020-09-30 $18.23B $6.23B 2.93
2020-06-30 $15.78B $6.01B 2.62
2020-03-31 $12.74B $5.50B 2.32
2019-12-31 $11.89B $6.20B 1.92
2019-09-30 $10.51B $5.84B 1.80
2019-06-30 $11.22B $7.51B 1.50
2019-03-31 $9.94B $5.90B 1.69
2018-12-31 $10.63B $6.15B 1.73
2018-09-30 $9.57B $5.20B 1.84
2018-06-30 $9.47B $5.98B 1.58
2018-03-31 $9.59B $7.07B 1.36
2017-12-31 $9.42B $7.05B 1.34
2017-09-30 $8.84B $7.03B 1.26
2017-06-30 $7.45B $5.08B 1.47
2017-03-31 $7.25B $5.30B 1.37
2016-12-31 $7.02B $4.87B 1.44
2016-09-30 $8.20B $5.26B 1.56
2016-06-30 $6.33B $5.53B 1.15
2016-03-31 $6.54B $6.32B 1.03
2015-12-31 $5.74B $4.15B 1.39
2015-09-30 $6.03B $5.74B 1.05
2015-06-30 $6.24B $6.10B 1.02
2015-03-31 $6.18B $6.86B 0.90
2014-12-31 $6.54B $5.35B 1.22
2014-09-30 $5.72B $6.22B 0.92
2014-06-30 $5.94B $6.24B 0.95
2014-03-31 $7.31B $5.39B 1.36
2013-12-31 $9.88B $3.13B 3.16
2013-09-30 $6.21B $2.45B 2.53
2013-06-30 $5.64B $2.36B 2.39
2013-03-31 $5.14B $2.30B 2.23
2012-12-31 $4.84B $2.09B 2.31
2012-09-30 $4.95B $2.52B 1.96
2012-06-30 $4.67B $2.70B 1.73
2012-03-31 $4.77B $2.85B 1.68
2011-12-31 $4.82B $3.11B 1.55
2011-09-30 $4.74B $2.79B 1.70
2011-06-30 $5.01B $1.82B 2.76
2011-03-31 $6.19B $4.15B 1.49
2010-12-31 $4.14B $1.71B 2.42
2010-09-30 $4.17B $1.77B 2.36
2010-06-30 $4.35B $1.62B 2.69
2010-03-31 $4.53B $1.78B 2.55
2009-12-31 $4.53B $1.64B 2.76
2009-09-30 $4.80B $1.59B 3.01
2009-06-30 $4.47B $1.52B 2.93
2009-03-31 $4.52B $1.50B 3.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $198.711B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $51.226B 36.24
Alcon (ALC) Switzerland $28.513B 24.14
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Globus Medical (GMED) United States $5.928B 30.24
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23